
Table of Contents
- What Is Pharmacy Forward?
- How AI Powers Clinical Care Teams
- Faster Medication Delivery Through AI
- Personalized Patient Support at Scale
- The Financial Case for Pharmacy Forward
- What Leaders Are Saying
What Is Pharmacy Forward?
Cigna’s Evernorth Health Services launched Pharmacy Forward on July 1, 2026 — a bold, AI-powered initiative designed to transform how specialty pharmacy care reaches patients. The program carries a $100 million investment through 2028 and initially launches through Evernorth’s Accredo Specialty Pharmacy, one of the largest specialty pharmacy networks in the United States.
Pharmacy Forward represents a fundamental shift in how health services companies are using artificial intelligence — not just for back-office efficiency, but to directly improve clinical outcomes and patient experiences. Furthermore, the program sets a new benchmark for what AI-enabled pharmacy care can accomplish at scale.
How AI Powers Clinical Care Teams
Smarter Clinical Decision-Making
Pharmacy Forward integrates three core data capabilities: clinical data aggregation, AI-generated summaries, and predictive analytics. Together, these tools give care teams a clearer, faster picture of each patient’s health status. As a result, clinicians can act earlier and more precisely.
Specifically, the program enables clinicians to proactively identify at-risk patients before their conditions escalate. This moves specialty pharmacy from a reactive model to a genuinely preventive one — a critical evolution in managing complex chronic conditions like cancer, rare diseases, and autoimmune disorders.
Cutting Documentation Time in Half
Administrative burden remains one of the biggest challenges in specialty care. Pharmacy Forward directly targets this problem. The program is anticipated to reduce documentation time by up to 50%, freeing clinicians to focus on patient care rather than paperwork. This efficiency gain is not trivial — it translates into more patients seen, more problems caught earlier, and fewer clinical errors rooted in fatigue or distraction.
Faster Medication Delivery Through AI
From Prescription to Patient — Faster
One of Pharmacy Forward’s most tangible goals is cutting the time between Accredo receiving a prescription and a patient receiving their medication in half. For patients managing serious, often life-altering conditions, every day matters. Consequently, Evernorth has built AI-driven workflows to accelerate the entire fulfillment cycle.
AI-Powered Prior Authorization
Prior authorization is frequently a bottleneck in specialty care delivery. Pharmacy Forward uses AI to ensure complete prior authorization submissions from the start, reducing back-and-forth delays with payers. Moreover, the system automatically determines copay assistance eligibility, removing financial barriers before they reach the patient.
Optimizing Specialty Medication Shipping
Accredo is also expanding its physical capacity across its care facilities to support faster delivery. Crucially, 90% of patients will now fall within a one- or same-day ground shipping radius for complex specialty medications. AI continuously monitors patient location, delivery timing, and medication handling requirements to identify the best dispensing location in real time.
Personalized Patient Support at Scale
AI-Enabled Scheduling and Digital Pathways
Beyond clinical care, Pharmacy Forward brings AI into the patient experience layer. Accredo now offers AI-enabled scheduling, reducing wait times and friction during care coordination. Additionally, the program expects a 25% increase in personalized patient digital pathway use — meaning more patients will follow structured, individualized care journeys rather than generic treatment protocols.
Reaching Patients Earlier
Pharmacy Forward also uses AI to engage patients earlier in their care journey. Proactive outreach, personalized education, and timely interventions are all enabled through the program’s digital infrastructure. This approach supports better medication adherence and helps patients navigate complex treatment regimens with less confusion and more confidence.
The Financial Case for Pharmacy Forward
The numbers behind Pharmacy Forward tell a compelling story. By the end of 2028, the program is expected to generate $400 million in total value — a 4x return on the original $100 million investment. This makes Pharmacy Forward not just a clinical initiative but a sound business strategy.
Evernorth also plans to expand Pharmacy Forward’s capabilities to its other pharmacy brands in the coming years, suggesting this is the foundation of a broader AI-driven pharmacy ecosystem rather than a one-time product launch. Investors and health plan partners should watch this space closely.
What Leaders Are Saying
Matt Perlberg, President of Evernorth Health Services’ pharmacy and care delivery businesses and Executive Vice President of Customer Innovation for The Cigna Group, underscored the mission behind the launch:
“Pharmacy Forward reflects our commitment to meet patients where they are — delivering an even faster, more seamless experience while ensuring they receive the personalized support and clinical care they deserve.”
His statement captures the dual mandate Evernorth is pursuing: speed and personalization, both at scale. Ultimately, Pharmacy Forward positions Evernorth as a leader in the next generation of AI-enabled specialty pharmacy care.

Pingback: Specialty Pharmacy Strategies by Insurers for 2026 / July 9, 2026
/